20 Nov
|
BioSpace
|
Canada
Lead drug product analytical development at Nurix Therapeutics in onsite Brisbane, California, applying chromatographic methods, dissolution expertise, and validation leadership.
This Senior Manager guides analytical development for oncology and inflammation and immunology programs. The work spans method development, CDMO and CRO oversight, stability studies, regulatory submissions, and late-phase technology transfer. You will shape analytical and quality control strategy for complex formulations, including amorphous solid dispersions and lipid-based systems.
Key Responsibilities:
- Lead analytical method development, validation, and lifecycle management
- Oversee CDMO and contract testing laboratory activities
- Design stability programs and analyze emerging trends
- Author analytical reports and regulatory submission sections
- Support PPQ, commercialization, and commercial quality control
Requirements:
- PhD in chemistry, pharmaceutics, or related field
- Eight or more years of industrial CMC experience
- Drug product analytical development and validation expertise
- Amorphous solid dispersion or lipid-based formulation experience
- Knowledge of ICH guidelines, cGMPs, and pharmacopeial chapters
Apply analytical development, validation, stability, and regulatory writing expertise to Nurix drug product programs in Brisbane.
📌 Senior Manager Drug Product Analytics (Canada)
🏢 BioSpace
📍 Canada